Active ingredientLoxapineCat. No. P-L100-001CAS 54810-23-0Family · Pharmaceutical analytical standards
Loxapine
A typical antipsychotic of the dibenzoxazepine class, approved in the United States in 1975 for schizophrenia; there is also an inhaled powder formulation for the rapid treatment of acute agitation. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?In the body part of it is converted into amoxapine, which is itself a tricyclic antidepressant drug.
Go to the active ingredient →Active ingredientLoxapineCat. No. P-L100-001CAS 54810-23-0
Active ingredientLoxapine SuccinateCat. No. P-L100-002CAS 27833-64-3
Pharmacopoeial impurityLoxapine USP Related Compound ACat. No. P-L100-003CAS 3454-96-4
Metabolite7-Hydroxy-Loxapine-O-GlucuronideCat. No. P-L100-005
Metabolite8-Hydroxy-Loxapine-O-GlucuronideCat. No. P-L100-006
MetaboliteLoxapine N+-GlucuronideCat. No. P-L100-007
Isotopically labelled7-Hydroxy-Loxapine-d8Cat. No. P-L100-008
Isotopically labelled8-Hydroxy-Loxapine-d8Cat. No. P-L100-009
Isotopically labelledLoxapine Impurity 2-d8Cat. No. P-L100-010
Isotopically labelledLoxapine Impurity 3 Iodide-d8Cat. No. P-L100-011
Isotopically labelledLoxapine-d8Cat. No. P-L100-012CAS 1189455-63-7
Impurity7-Hydroxy-LoxapineCat. No. P-L100-013
Impurity7-Hydroxy-Loxapine N-OxideCat. No. P-L100-014CAS 37081-77-9
Impurity7-Hydroxy-Loxapine SulfateCat. No. P-L100-015
Impurity8-Hydroxy LoxapineCat. No. P-L100-016CAS 61443-77-4
Impurity8-Hydroxy-Loxapine N-OxideCat. No. P-L100-017
Impurity8-Hydroxy-Loxapine SulfateCat. No. P-L100-018
ImpurityLoxapine N-OxideCat. No. P-L100-019CAS 25967-34-4
ImpurityLoxapine Impurity 1 (LOXO-195)Cat. No. P-L100-020CAS 2097002-61-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.